BO-653

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBO-653
Drug Alias NameBO-653
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid peroxidation inhibitors
TargetsNot applicable
Therapy Area/IndicationsGraft Occlusion, VascularAtherosclerosisCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChugai Pharma USA, Inc
Active IndicationsN/A
Inactive IndicationsGraft Occlusion, VascularAtherosclerosisCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A